1.

2.
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [F-18]FDG: version 1.0
by Law, Ian
European journal of nuclear medicine and molecular imaging, 2019, Vol.46 (3), p.540-557

3.
Aberrant intestinal microbiota in individuals with prediabetes
by Allin, Kristine H
Diabetologia, 2018, Vol.61 (4), p.810-820

4.
Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study
by Bryrup, Thomas
Diabetologia, 2019, Vol.62 (6), p.1024-1035

5.
Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe
by Egan, Aoife M
Diabetologia, 2017, Vol.60 (10), p.1913-1921

6.
Afternoon exercise is more efficacious than morning exercise at improving blood glucose levels in individuals with type 2 diabetes: a randomised crossover trial
by Savikj, Mladen
Diabetologia, 2018, Vol.62 (2), p.233-237

7.
Transcriptomic profiling of pancreatic alpha, beta and delta cell populations identifies delta cells as a principal target for ghrelin in mouse islets
by Adriaenssens, Alice E
Diabetologia, 2016, Vol.59 (10), p.2156-2165

8.
Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts
by Ahola-Olli, Ari V
Diabetologia, 2019, Vol.62 (12), p.2298-2309

9.
Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies
by Kristensen, Karl
Diabetologia, 2019, Vol.62 (7), p.1143-1153

10.
Metabolic profiling of gestational diabetes in obese women during pregnancy
by White, Sara L
Diabetologia, 2017, Vol.60 (10), p.1903-1912

11.
Epigenetics and gestational diabetes: a review of epigenetic epidemiology studies and their use to explore epigenetic mediation and improve prediction
by Elliott, Hannah R
Diabetologia, 2019, Vol.62 (12), p.2171-2178

12.

13.
A reduction in sedentary behaviour in obese women during pregnancy reduces neonatal adiposity: the DALI randomised controlled trial
by van Poppel, MNM
Diabetologia, 2019, Vol.62 (6), p.915-925

14.
Self-disorders in schizophrenia-spectrum disorders: a 5-year follow-up study
by Nordgaard, Julie
European archives of psychiatry and clinical neuroscience, 2017, Vol.268 (7), p.713-718

15.
The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice
by Ørgaard, Anne
Diabetologia, 2017, Vol.60 (9), p.1731-1739

16.
Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
by Welsh, Paul
Diabetologia, 2018, Vol.61 (7), p.1581-1591

17.
Paternal impact on the life course development of obesity and type 2 diabetes in the offspring
by Sharp, Gemma C
Diabetologia, 2019, Vol.62 (10), p.1802-1810

18.
Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study
by But, Anna
Diabetologia, 2017, Vol.60 (9), p.1691-1703

19.
Translating HbA1c measurements into estimated average glucose values in pregnant women with diabetes
by Law, Graham R
Diabetologia, 2017, Vol.60 (4), p.618-624

20.
Interleukin-6 induces impairment in human subcutaneous adipogenesis in obesity-associated insulin resistance
by Almuraikhy, Shamma
Diabetologia, 2016, Vol.59 (11), p.2406-2416
